162 related articles for article (PubMed ID: 35167714)
1. Fusion-positive skin/adnexal carcinomas.
Agaimy A
Genes Chromosomes Cancer; 2022 May; 61(5):274-284. PubMed ID: 35167714
[TBL] [Abstract][Full Text] [Related]
2. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
[TBL] [Abstract][Full Text] [Related]
3. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
[TBL] [Abstract][Full Text] [Related]
5. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
6. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
[TBL] [Abstract][Full Text] [Related]
7. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
Christensen DJ; Tuluc M
J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
[TBL] [Abstract][Full Text] [Related]
8. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
[TBL] [Abstract][Full Text] [Related]
9. Skin adnexal carcinoma with BRD3-NUTM2B fusion.
Rubio Gonzalez B; Ortiz MV; Ross DS; Busam KJ
J Cutan Pathol; 2021 Dec; 48(12):1508-1513. PubMed ID: 34296453
[TBL] [Abstract][Full Text] [Related]
10. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
11. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
Parra O; Kerr DA; Bridge JA; Loehrer AP; Linos K
J Cutan Pathol; 2021 Jan; 48(1):95-101. PubMed ID: 32757412
[TBL] [Abstract][Full Text] [Related]
12. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
[TBL] [Abstract][Full Text] [Related]
13. The expanding universe of NUTM1 fusions in pediatric cancer.
Charlab R; Racz R
Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion.
Shah A; Box A; Brenn T; Flaman A
J Cutan Pathol; 2024 Jun; 51(6):424-429. PubMed ID: 38481096
[TBL] [Abstract][Full Text] [Related]
15. Primary Spindle Cell Sarcoma of the Lung with
Georgantzoglou N; Aghighi M; Cote G; Hung YP; Kerr DA; Pettus J; Linos K
Int J Surg Pathol; 2022 Dec; 30(8):931-938. PubMed ID: 35388715
[TBL] [Abstract][Full Text] [Related]
16. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
[TBL] [Abstract][Full Text] [Related]
17. NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity.
Xu B; Chen JF; Sarungbam J; Tickoo S; Dickson BC; Reuter VE; Antonescu CR
Genes Chromosomes Cancer; 2022 Sep; 61(9):542-550. PubMed ID: 35430756
[TBL] [Abstract][Full Text] [Related]
18. Emerging entities in NUTM1-rearranged neoplasms.
McEvoy CR; Fox SB; Prall OWJ
Genes Chromosomes Cancer; 2020 Jun; 59(6):375-385. PubMed ID: 32060986
[TBL] [Abstract][Full Text] [Related]
19. High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient.
Arellano Zameza P; Karklins SP; Pena J; Bowers NL; Samman A; Ahn C; Sangueza OP
Am J Dermatopathol; 2024 Feb; 46(2):101-103. PubMed ID: 38055974
[TBL] [Abstract][Full Text] [Related]
20. CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.
Schaefer IM; Dal Cin P; Landry LM; Fletcher CDM; Hanna GJ; French CA
Genes Chromosomes Cancer; 2018 Sep; 57(9):446-451. PubMed ID: 29700887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]